No significant difference in survival or neurologic outcomes between intraosseous and intravenous vascular access in out-of-hospital cardiac arrest was found.
“You are instilling fear into folks who may defer care, who may go without care, whose children may not get the vaccines they need, who may not be able to get treatment for an ear infection or surgery."
TAHO Pharmaceuticals completes pivotal trial of the first oral dissolving film anticoagulant, potentially transforming how life-saving therapies are delivered.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.
Researchers have found that out-of-hospital cardiac arrests caused by anaphylaxis are associated with better neurological outcomes and higher survival rates compared to those caused by cardiac conditions.